Kingdon Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-60,216
Closed -$10.1M 78
2019
Q3
$10.1M Buy
60,216
+10,216
+20% +$1.66M 1.2% 35
2019
Q2
$8.37M Buy
+50,000
New +$6.92M 0.82% 41
2016
Q2
Sell
-48,678
Closed -$13M 140
2016
Q1
$13M Buy
48,678
+7,972
+20% +$2.28M 0.72% 41
2015
Q4
$12.7M Sell
40,706
-23,758
-37% -$7.07M 0.62% 50
2015
Q3
$17.5M Sell
64,464
-86,043
-57% -$26.4M 0.84% 40
2015
Q2
$45.7M Buy
150,507
+51,678
+52% +$15.4M 1.79% 13
2015
Q1
$29.4M Sell
98,829
-90,740
-48% -$25.9M 1.25% 14
2014
Q4
$48.8M Buy
189,569
+128,100
+208% +$32M 2.12% 11
2014
Q3
$14.8M Buy
61,469
+11,569
+23% +$2.59M 0.67% 39
2014
Q2
$11.1M Buy
49,900
+22,150
+80% +$4.59M 0.43% 71
2014
Q1
$5.71M Sell
27,750
-9,700
-26% -$1.92M 0.29% 98
2013
Q4
$6.29M Buy
37,450
+12,450
+50% +$1.95M 0.29% 107
2013
Q3
$3.6M Buy
+25,000
New +$3.33M 0.18% 139

Other funds holding AGN

Kingdon Capital Management's AGN Position: Q4 2019 in Review

Kingdon Capital Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 60,216 shares — an estimated $10.1M sold.

Kingdon Capital Management first reported a position in AGN in Q3 2013 and held it in 13 quarters. The position peaked at $48.8M in Q4 2014. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Kingdon Capital Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Kingdon Capital Management sold 60,216 Allergan plc shares in Q4 2019, an estimated $10.1M.
  • Kingdon Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 13 quarters.
  • Kingdon Capital Management's Allergan plc position peaked at $48.8M in Q4 2014.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.